Top 10 Articles
Top Article: Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
Abstract:
Background: Bevacizumab has recently been approved by the US Food and Drug Administration for recurrent glioblastoma (GBM). However, patterns of relapse, prognosis, and outcome of further therapy after bevacizumab failure have not been studied systematically.
Methods: We identified patients… Continue Reading
Methods: We identified patients… Continue Reading










by Alexandre Bisdorff
The UEMS (Union Européenne des Médecins Spécialistes – www.uems.net) was founded in 1958 and is constituted by the national medical associations of EU member states and European Economic Area countries (as full members). Additional 4 countries have…
by Samyra Keus
At the end of this year, the first European Physiotherapy Guideline for Parkinson’s Disease will be published, providing evidence-based recommendations for physiotherapy care in Parkinson’s disease: Why and when should patients be referred? What interventions should be…